Pathstone Holdings »

Gracell Biotechnologies shares owned by Pathstone Holdings

Quarter-by-quarter ownership of Gracell Biotechnologies shares owned by Pathstone Holdings from 13F filings

Historical chart of Pathstone Holdings investment in Gracell Biotechnologies

Tip: Access up to 7 years of quarterly data

All positions including Gracell Biotechnologies held by Pathstone Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gracell Biotechnologies by Pathstone Holdings

Quarter filed Position value Share count Share price at filing
2023-12-31 $494k 49k 10.04

More positions owned by Pathstone Holdings

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Crowdstrike Hldgs Cl A (CRWD)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Rus 1000 Etf (IWB)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Index Fds Large Cap Etf (VV)
Coca-Cola Company (KO)
Amazon (AMZN)
Ishares Tr Russell 2000 Etf (IWM)

View all positions for Pathstone Holdings

Top funds holding Gracell Biotechnologies

OrbiMed Advisors
Tang Capital Management
Baker Bros. Advisors
Pentwater Capital Management
TIG Advisors
Alpine Associates Management
Octagon Capital Advisors
Bank of America Corporation
LMR Partners
Sphera Funds Management
MMCAP International Inc. SPC
Hudson Bay Capital Management
Marshall Wace
Millennium Management
CNH Partners

View all funds holding Gracell Biotechnologies